Status:
RECRUITING
Reperfusion Injury After Endovascular Stroke Treatment
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
Medical University Innsbruck
Paracelsus Medical University
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Endovascular stroke treatment with mechanical thrombectomy (MT) has become the standard therapy for intracranial large vessel occlusion (LVO). The most serious MT-related complication is secondary int...
Detailed Description
Endovascular stroke treatment with mechanical thrombectomy (MT) has become the standard therapy for intracranial large vessel occlusion (LVO). The most serious MT-related complication is secondary int...
Eligibility Criteria
Inclusion
- stroke due to large vessel occlusion of the anterior cerebral circulation (internal carotid artery, middle cerebral artery) receiving mechanical thrombectomy.
Exclusion
- basilar artery occlusion
- age below 18 years
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05273216
Start Date
October 1 2021
End Date
July 1 2026
Last Update
June 13 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Univerity of Graz, Department of Neurology
Graz, Styria, Austria, 8036
2
Medical University of Innsbruck, Department of Neurology
Innsbruck, Tyrol, Austria, 6020
3
Paracelsus Medical University, Department of Neurology
Salzburg, Austria, 5020